Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax
{{output}}
Objective: This study aimed to describe treatment sequencing and healthcare costs among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients treated with venetoclax in a US managed care population. ... ...
